PL2719391T3 - Sposób podawania surfaktanta płucnego - Google Patents

Sposób podawania surfaktanta płucnego

Info

Publication number
PL2719391T3
PL2719391T3 PL14150705T PL14150705T PL2719391T3 PL 2719391 T3 PL2719391 T3 PL 2719391T3 PL 14150705 T PL14150705 T PL 14150705T PL 14150705 T PL14150705 T PL 14150705T PL 2719391 T3 PL2719391 T3 PL 2719391T3
Authority
PL
Poland
Prior art keywords
administration
pulmonary surfactant
pulmonary
surfactant
Prior art date
Application number
PL14150705T
Other languages
English (en)
Inventor
Egbert Herting
Wolfgang Gopel
Paolo Chiesi
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of PL2719391T3 publication Critical patent/PL2719391T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL14150705T 2007-06-08 2008-05-23 Sposób podawania surfaktanta płucnego PL2719391T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/811,351 US8048043B2 (en) 2007-06-08 2007-06-08 Method of administration of a pulmonary surfactant

Publications (1)

Publication Number Publication Date
PL2719391T3 true PL2719391T3 (pl) 2017-06-30

Family

ID=39832595

Family Applications (2)

Application Number Title Priority Date Filing Date
PL08758716T PL2164504T3 (pl) 2007-06-08 2008-05-23 Sposób podawania surfaktanta płucnego
PL14150705T PL2719391T3 (pl) 2007-06-08 2008-05-23 Sposób podawania surfaktanta płucnego

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL08758716T PL2164504T3 (pl) 2007-06-08 2008-05-23 Sposób podawania surfaktanta płucnego

Country Status (23)

Country Link
US (2) US8048043B2 (pl)
EP (2) EP2164504B1 (pl)
JP (1) JP5490683B2 (pl)
KR (2) KR101344159B1 (pl)
CN (1) CN101765431B (pl)
AU (1) AU2008258872B2 (pl)
BR (1) BRPI0811387B8 (pl)
CA (1) CA2690097C (pl)
CY (2) CY1116680T1 (pl)
DK (2) DK2164504T3 (pl)
EA (1) EA016308B1 (pl)
ES (2) ES2616727T3 (pl)
HK (1) HK1141457A1 (pl)
HR (2) HRP20150966T1 (pl)
HU (2) HUE031750T2 (pl)
LT (1) LT2719391T (pl)
ME (1) ME02327B (pl)
MX (2) MX359316B (pl)
PL (2) PL2164504T3 (pl)
PT (2) PT2719391T (pl)
RS (2) RS55733B1 (pl)
SI (2) SI2164504T1 (pl)
WO (1) WO2008148469A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102470150B (zh) * 2009-09-08 2013-12-11 奇斯药制品公司 包含肺表面活性物质和抗氧化酶的治疗组合物
RU2504395C1 (ru) * 2012-07-13 2014-01-20 ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ И СОЦИАЛЬНОГО РАЗВИТИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ/ФГБУ "РНЦРХТ" Минздравсоцразвития России Способ профилактики бронхолегочной дисплазии у новорожденных с очень низкой и экстремально низкой массой тела при рождении
ITMI20150033U1 (it) * 2015-02-13 2016-08-13 Chiesi Farm Spa Catetere per la somministrazione di un surfattante polmonare
US10905836B2 (en) 2015-04-02 2021-02-02 Hill-Rom Services Pte. Ltd. Manifold for respiratory device
US11311691B2 (en) 2015-04-28 2022-04-26 Chiesi Farmaceutici S.P.A Device for facilitating the administration of a medicament to the lung by a catheter
US20180147262A1 (en) * 2015-04-30 2018-05-31 University Of Bremen Novel skin medical and cosmetic care product
CA3028551A1 (en) 2016-07-28 2018-02-01 Chiesi Farmaceutici S.P.A. Method and system for delivery of an aerosolized medicament
MA46605A (fr) 2016-10-26 2021-06-02 Chiesi Farm Spa Dispositif permettant de faciliter l'administration d'un médicament aux poumons par l'intermédiaire d'un cathéter
AU2017384467B2 (en) 2016-12-22 2023-10-19 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid for the treatment of evolving BPD
MX2020011127A (es) 2018-04-23 2021-01-15 Chiesi Farm Spa Combinacion terapeutica que comprende agente tensioactivo pulmonar y esteroide para la profilaxis de displasia broncopulmonar (bpd).
WO2020114895A1 (en) 2018-12-06 2020-06-11 Chiesi Farmaceutici S.P.A. Laryngeal mask airway device and method for administering a medicament through a laryngeal mask airway device
US11219843B2 (en) * 2019-07-08 2022-01-11 Nik Paya Karen Pharmed Extraction of animal-derived pulmonary surfactants
EP4097128A1 (en) 2020-01-28 2022-12-07 Chiesi Farmaceutici S.p.A. Polypeptides having improved properties
WO2023280737A1 (en) * 2021-07-05 2023-01-12 Chiesi Farmaceutici S.P.A. Process for the preparation of a pulmonary surfactant
CN115634199B (zh) * 2022-10-18 2024-05-03 杭州汉库医药科技有限公司 一种混悬型肺表面活性物质注射液及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164369A (en) 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US5260273A (en) 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
DE4418936A1 (de) 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
GB9524007D0 (en) * 1995-11-23 1996-01-24 Bangham Alec D Endotrachael tubes with pulmonary medicaments
IT1308180B1 (it) 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
DK1440083T3 (da) * 2001-10-25 2013-03-25 Medical Res Council Molekyler
EP1897577B1 (de) * 2002-08-02 2012-05-16 Med In Medical Innovations GmbH Vorrichtung zur Erzeugung eines kontinuierlichen positiven Atemwegdrucks (CPAP-Vorrichtung)
US20060040860A1 (en) * 2004-06-17 2006-02-23 Mario Ruediger Intra-tracheal application of vascular endothelial growth factor (VEGF) for the prevention of lung damages caused by hperoxia
US20060112961A1 (en) * 2004-11-29 2006-06-01 Hany Aly Pediatric mask, especially suited for premature infants
AU2006203978B2 (en) * 2005-01-06 2011-11-03 Discovery Laboratories, Inc. Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia

Also Published As

Publication number Publication date
US20120017896A1 (en) 2012-01-26
PT2164504E (pt) 2015-10-16
BRPI0811387B1 (pt) 2018-11-06
SI2164504T1 (sl) 2015-10-30
HK1141457A1 (en) 2010-11-12
US20080305180A1 (en) 2008-12-11
DK2164504T3 (en) 2015-10-12
HRP20170270T1 (hr) 2017-04-21
CA2690097A1 (en) 2008-12-11
AU2008258872A1 (en) 2008-12-11
ES2547489T3 (es) 2015-10-06
KR101399738B1 (ko) 2014-05-27
LT2719391T (lt) 2017-02-10
WO2008148469A1 (en) 2008-12-11
CY1116680T1 (el) 2017-03-15
HUE025957T2 (en) 2016-05-30
EA200901499A1 (ru) 2010-06-30
CA2690097C (en) 2018-05-22
MX2009012835A (es) 2009-12-15
CN101765431A (zh) 2010-06-30
JP5490683B2 (ja) 2014-05-14
HUE031750T2 (en) 2017-07-28
RS54196B1 (en) 2015-12-31
ME02327B (me) 2016-06-20
EP2164504B1 (en) 2015-07-29
AU2008258872B2 (en) 2012-10-04
JP2010528729A (ja) 2010-08-26
DK2719391T3 (en) 2017-02-20
EP2719391B1 (en) 2016-11-30
RS55733B1 (sr) 2017-07-31
MX359316B (es) 2018-09-25
BRPI0811387B8 (pt) 2021-05-25
HRP20150966T1 (hr) 2015-10-09
EP2719391A1 (en) 2014-04-16
KR20100028530A (ko) 2010-03-12
BRPI0811387A2 (pt) 2015-07-21
US8048043B2 (en) 2011-11-01
EA016308B1 (ru) 2012-04-30
SI2719391T1 (sl) 2017-03-31
PT2719391T (pt) 2017-03-02
US8905979B2 (en) 2014-12-09
KR101344159B1 (ko) 2013-12-23
PL2164504T3 (pl) 2016-01-29
CN101765431B (zh) 2013-04-03
CY1118635T1 (el) 2017-07-12
KR20130038940A (ko) 2013-04-18
EP2164504A1 (en) 2010-03-24
ES2616727T3 (es) 2017-06-14

Similar Documents

Publication Publication Date Title
LT2719391T (lt) Plaučių paviršiaus aktyvios medžiagos įvedimo būdas
IL205038A0 (en) Method of establishing a connection
GB0611312D0 (en) Intranasal administration
EP2339918A4 (en) PREPARATION OF A QUINOLINYLOXYDIPHENYLCYCLOPROPANEDICARBOXAMIDE
PT2246336T (pt) Inibidor de fibrose
GB0811942D0 (en) Method of designing a structure
PL1961770T3 (pl) Sposób wytwarzania kompleksu
GB2455054B (en) Method of manufacturing a finfet
EP2136391A4 (en) dry
PL2169142T3 (pl) Sposób wytwarzania podłogi
EP2344192A4 (en) METHOD FOR MANUFACTURING A VACCINE
GB2460908B (en) Golf aid
EP2148360A4 (en) dry
GB0702241D0 (en) A method of handover
EP2133310A4 (en) PROCESS FOR STABILIZING GIPS
GB2464340B (en) Play structures
EP2252149A4 (en) PROCESS FOR PREPARING FENTANYLE
ZA200907537B (en) A method for the preparation of mirtazapine
GB0721991D0 (en) Preparation method
EP2172217A4 (en) FIBROSIS INHIBITOR
GB2464076B (en) A method of building construction
GB2455698B (en) A method of manufacturing panels
GB0809352D0 (en) Method of modifying modular constructions
ZA200809784B (en) A method of facilitating lift clubs
GB0700289D0 (en) Method of synchronising